AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance CAMTS training standards
Number of subjects: 12
Study 21798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intubation attempts
Number of subjects: 12
Study 21798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Time per attempt
Number of subjects: 12
Study 19494439 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 800 IU per day for six months
Number of subjects: 57
Study 19494439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 16755160 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate supplementation (5 mg oral daily or 5 mg every other day)
Number of subjects: 114
Study 16755160 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (Control group)
Number of subjects: 114
Study 16755160 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with low homocysteine levels and treated with folate
Number of subjects: 114
Study 16755160 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with high homocysteine and low protein catabolic rate
Number of subjects: 114
Study 15311666 — intervention group
Group type: EXPERIMENTAL
Intervention: Convex mirror
Number of subjects: 66
Study 15311666 — intervention group
Group type: COMPARATOR
Intervention: Plane mirror
Number of subjects: 66
Study 15311666 — intervention group
Group type: EXPERIMENTAL
Intervention: Both mirrors
Number of subjects: 66
Study 15311666 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking-into-account model
Number of subjects: 66
Study 15311666 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct perception model
Number of subjects: 66
Study 10806471 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft music (60-70 dB)
Number of subjects: 144
Study 10806471 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium music (70-80 dB)
Number of subjects: 144
Study 10806471 — intervention group
Group type: EXPERIMENTAL
Intervention: Loud music (80-90 dB)
Number of subjects: 144
Study 10806471 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate monitoring
Number of subjects: 144
Study 10806471 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report data
Number of subjects: 144
Study 9055717 — intervention group
Group type: EXPERIMENTAL
Intervention: Community thrombolysis (intravenous anistreplase administered by general practitioners)
Number of subjects: 311
Study 9055717 — intervention group
Group type: COMPARATOR
Intervention: Hospital thrombolysis (intravenous anistreplase administered by secondary care clinicians)
Number of subjects: 311
Study 8128466 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 U/kg rhEPO
Number of subjects: 43
Study 8128466 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 U/kg rhEPO
Number of subjects: 43
Study 8128466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 8128466 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 U/kg rhEPO
Number of subjects: 43
Study 8128466 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 U/kg rhEPO
Number of subjects: 43
Study 8128466 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study 3112263 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 30
Study 3112263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29183752 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based exercise program (COMBEX)
Number of subjects: 18
Study 29183752 — intervention group
Group type: COMPARATOR
Intervention: Day hospital-based exercise program (DAYEX)
Number of subjects: 18
Study 30621479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 L polyethylene glycol with ascorbic acid plus 2 mg prucalopride (1LP/AP)
Number of subjects: 260
Study 30621479 — intervention group
Group type: COMPARATOR
Intervention: 2 L polyethylene glycol with ascorbic acid (2LP/A)
Number of subjects: 260
Study 26820220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) at birth (25 cmH2O for 15 seconds)
Number of subjects: 185
Study 26820220 — intervention group
Group type: COMPARATOR
Intervention: Control group (CPAP or assistance as per AAP recommendations)
Number of subjects: 185
Study 26820220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) at birth
Number of subjects: 185
Study 26820220 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185
Study 24990426 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) intervention
Number of subjects: 7187
Study 24990426 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 7187
Study 24990426 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline triglycerides
Number of subjects: 7187
Study 22843897 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle strength training (lifting standardized weights weekly at 50% of h1RM)
Number of subjects: 0
Study 22843897 — intervention group
Group type: COMPARATOR
Intervention: Conventional gymnastic exercises
Number of subjects: 0
Study 21092037 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion therapy after cardiopulmonary bypass with fibrinogen administration combined with traditional transfusion, guided by TEG (Group F)
Number of subjects: 31
Study 21092037 — intervention group
Group type: COMPARATOR
Intervention: Traditional transfusion guided by clinical experiences only (Group C)
Number of subjects: 31
Study 18510730 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management by advanced practice nurses
Number of subjects: 35
Study 15677796 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial biopsy and RT-PCR analysis of RAGE and MCP-1 transcripts
Number of subjects: 12
Study 12750062 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐monomethyl‐L‐arginine (L‐NMMA; 3 mg/kg over 5 min)
Number of subjects: 12
Study 12750062 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐monomethyl‐L‐arginine (L‐NMMA; 6 mg/kg over 5 min)
Number of subjects: 12
Study 12750062 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 12750062 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐monomethyl‐L‐arginine (L‐NMMA; 3 mg/kg and 6 mg/kg)
Number of subjects: 12
Study 10371111 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily for 4 weeks)
Number of subjects: 77
Study 10371111 — intervention group
Group type: COMPARATOR
Intervention: CABG without preoperative lipid control
Number of subjects: 77
Study 9009787 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of mortality
Number of subjects: 0
Study 9009787 — intervention group
Group type: COMPARATOR
Intervention: Symbolic immortality (two forms)
Number of subjects: 0
Study 1642662 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg oral tiludronate
Number of subjects: 149
Study 1642662 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg oral tiludronate
Number of subjects: 149
Study 1642662 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg oral tiludronate
Number of subjects: 149
Study 1642662 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg oral tiludronate
Number of subjects: 149
Study 1642662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 6881451 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary common bile duct closure
Number of subjects: 117
Study 6881451 — intervention group
Group type: COMPARATOR
Intervention: T‐tube drainage
Number of subjects: 117
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (low infusion rate: 0.5 μg · kg · h; moderate infusion rate: 1.5 μg · kg · h)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (low infusion rate: 42 μg · kg · min; moderate infusion rate: 83 μg · kg · min)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (low infusion rate)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (low infusion rate)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (moderate infusion rate)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (moderate infusion rate)
Number of subjects: 12
Study 31403974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and Propofol (both infusion rates)
Number of subjects: 12
Study 28771064 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU of cholecalciferol every two weeks for 11-12 weeks)
Number of subjects: 57
Study 28771064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 28771064 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 57
Study 26088568 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurse‐mediated intervention
Number of subjects: 1492
Study 26088568 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 1492
Study 26088568 — intervention group
Group type: COMPARATOR
Intervention: Practice nurse‐mediated usual care
Number of subjects: 1492
Study 26088568 — intervention group
Group type: COMPARATOR
Intervention: Standard usual care
Number of subjects: 1492
Study 24738117 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture closure of the subcutaneous tissue
Number of subjects: 361
Study 24738117 — intervention group
Group type: COMPARATOR
Intervention: Non-closure of the subcutaneous tissue
Number of subjects: 361
Study 21236699 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 3069
Study 21236699 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipophilic statins
Number of subjects: 3069
Study 21236699 — intervention group
Group type: COMPARATOR
Intervention: Lipid-lowering medications (LLMs) including statins
Number of subjects: 3069
Study 19216654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) combined with ginsenosides (GS)
Number of subjects: 120
Study 19216654 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (Dex)
Number of subjects: 120
Study 19216654 — intervention group
Group type: COMPARATOR
Intervention: Ginsenosides (GS)
Number of subjects: 120
Study 18070466 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 150
Study 18070466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 150
Study 18070466 — intervention group
Group type: COMPARATOR
Intervention: No statin
Number of subjects: 150
Study 15142010 — intervention group
Group type: EXPERIMENTAL
Intervention: High Carbohydrate (HC) meal (79% carbohydrate, 20% protein, 1% fat)
Number of subjects: 9
Study 15142010 — intervention group
Group type: EXPERIMENTAL
Intervention: High Fat (HF) meal (37% carbohydrate, 18% protein, 45% fat)
Number of subjects: 9
Study 15142010 — intervention group
Group type: COMPARATOR
Intervention: Water (CON)
Number of subjects: 9
Study 11520776 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorable risk group (t(15;17), t(8;21), or inv(16))
Number of subjects: 1065
Study 11520776 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal karyotype
Number of subjects: 1065
Study 11520776 — intervention group
Group type: EXPERIMENTAL
Intervention: Other noncomplex abnormalities
Number of subjects: 1065
Study 11520776 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex karyotype
Number of subjects: 1065
Study 16296679 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors (Sahvatex, Denmark) fitted into specially designed undergarments, used over a 3-month period.
Number of subjects: 101
Study 7945126 — intervention group
Group type: EXPERIMENTAL
Intervention: cinnarizine 50 mg
Number of subjects: 95
Study 7945126 — intervention group
Group type: EXPERIMENTAL
Intervention: cinnarizine 25 mg
Number of subjects: 95
Study 7945126 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95
Study 2855116 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.6 g/kg)
Number of subjects: 6
Study 2855116 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.2 g/kg)
Number of subjects: 6
Study 2855116 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (1.3% delta 9‐THC)
Number of subjects: 6
Study 2855116 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (2.7% delta 9‐THC)
Number of subjects: 6
Study 2855116 — intervention group
Group type: COMPARATOR
Intervention: Alcohol (0 g/kg)
Number of subjects: 6
Study 2855116 — intervention group
Group type: COMPARATOR
Intervention: Marijuana (0% delta 9‐THC)
Number of subjects: 6
Study 31788849 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg rectal diclofenac administered 30 minutes before ERCP
Number of subjects: 297
Study 31788849 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diclofenac)
Number of subjects: 297
Study 31788849 — intervention group
Group type: COMPARATOR
Intervention: Both groups (diclofenac and control)
Number of subjects: 297
Study 29698251 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program‐Brazilian version (TAP‐BR) over 4 months
Number of subjects: 30
Study 29698251 — intervention group
Group type: COMPARATOR
Intervention: Usual care (wait-list control group)
Number of subjects: 30
Study 25953193 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplements (Lactobacillus reuteri)
Number of subjects: 49
Study 25953193 — intervention group
Group type: COMPARATOR
Intervention: Placebo (topical oil application and lozenges)
Number of subjects: 49
Study 24756186 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg oral)
Number of subjects: 54
Study 24756186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 23086785 — intervention group
Group type: EXPERIMENTAL
Intervention: Transapical (TA) procedure
Number of subjects: 105
Study 23086785 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral (TF) procedure
Number of subjects: 105
Study 20420674 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 60
Study 20420674 — intervention group
Group type: COMPARATOR
Intervention: Cortisone
Number of subjects: 60
Study 18231834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure hemorrhoidectomy
Number of subjects: 273
Study 18231834 — intervention group
Group type: COMPARATOR
Intervention: Conventional diathermy hemorrhoidectomy
Number of subjects: 273
Study 15746470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun-protective clothing (investigator-provided garments made from fabrics with ultraviolet protection factors rated very good to excellent)
Number of subjects: 652
Study 15746470 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 652
Study 12504938 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 40 mg
Number of subjects: 0
Study 12504938 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 20 mg
Number of subjects: 0
Study 10634836 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sodium supplementation (4 mmol/kg/day starting on the second day after birth)
Number of subjects: 46
Study 10634836 — intervention group
Group type: COMPARATOR
Intervention: Delayed sodium supplementation (4 mmol/kg/day starting when weight loss of 6% of birthweight was achieved)
Number of subjects: 46
Study 10634836 — intervention group
Group type: COMPARATOR
Intervention: Delayed sodium supplementation
Number of subjects: 46
Study 8859725 — intervention group
Group type: EXPERIMENTAL
Intervention: THERATOPE STn‐KLH cancer vaccine emulsified in DETOX adjuvant
Number of subjects: 85
Study 8859725 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐dose intravenous cyclophosphamide before ASI
Number of subjects: 85
Study 8859725 — intervention group
Group type: EXPERIMENTAL
Intervention: Postimmunization increase in anti‐OSM IgM titer
Number of subjects: 85
Study 8859725 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased anti‐OSM IgG titers
Number of subjects: 85
Study 8859725 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased pre‐ASI CA‐125 serum levels
Number of subjects: 85
Study 8859725 — intervention group
Group type: COMPARATOR
Intervention: Anti‐KLH antibody titers
Number of subjects: 85
Study 1516489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent glyburide therapy (2 weeks on, 2 weeks off)
Number of subjects: 28
Study 1516489 — intervention group
Group type: COMPARATOR
Intervention: Continuous glyburide therapy
Number of subjects: 28
Study 6509985 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital insertion of IUD
Number of subjects: 114
Study 6509985 — intervention group
Group type: COMPARATOR
Intervention: Surgical forceps insertion of IUD
Number of subjects: 114
Study 6509985 — intervention group
Group type: EXPERIMENTAL
Intervention: Inexperienced inserters
Number of subjects: 114
Study 30789347 — intervention group
Group type: EXPERIMENTAL
Intervention: Education Against Tobacco (EAT) intervention (90 minutes of mentoring in a classroom setting)
Number of subjects: 2348
Study 30789347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2348
Study 30789347 — intervention group
Group type: EXPERIMENTAL
Intervention: Education Against Tobacco (EAT) intervention
Number of subjects: 2348
Study 29253154 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 788
Study 29253154 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 788
Study 26540163 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention combining telemonitoring, medication management, self-management support, and depression management.
Number of subjects: 50
Study 26540163 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 50
Study 26540163 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 24910934 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA; onabotulinumtoxinA) injections; Female participants received 29 units; Male participants received 39 units
Number of subjects: 30
Study 24910934 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA; onabotulinumtoxinA) injections
Number of subjects: 30
Study 21702046 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal immunochemical test (FIT) screening
Number of subjects: 4407
Study 21702046 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage recruitment for FS and FIT screening
Number of subjects: 4407
Study 21702046 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT screening
Number of subjects: 4407
Study 21702046 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage recruitment
Number of subjects: 4407
Study 20368402 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) and Artesunate (AS) combination therapy
Number of subjects: 54
Study 18071282 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% ethanol
Number of subjects: 74
Study 18071282 — intervention group
Group type: COMPARATOR
Intervention: 20% hypertonic saline (HS)
Number of subjects: 74
Study 15996811 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin gastrointestinal therapeutic system (DOX GITS) 4 mg/d
Number of subjects: 213
Study 15996811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 14507273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium (Ca) 1 g
Number of subjects: 23
Study 14507273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium (Ca) 2 g
Number of subjects: 23
Study 14507273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium (Ca) 4 g
Number of subjects: 23
Study 14507273 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium (Ca)
Number of subjects: 23
Study 14507273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 14507273 — intervention group
Group type: EXPERIMENTAL
Intervention: Plateletpheresis
Number of subjects: 23
Study 10768522 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 106
Study 10768522 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg granisetron
Number of subjects: 106
Study 10768522 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 106
Study 8644427 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy including 5-fluorouracil and leucovorin
Number of subjects: 0
Study 8644427 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil in combination with levamisole or leucovorin
Number of subjects: 0
Study 8644427 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 0
Study 1998792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pill
Number of subjects: 24
Study 1998792 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping the combined oral contraceptive pill
Number of subjects: 24
Study 6147193 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 399 syrup (combination of azatadine maleate, pseudoephedrine sulfate, and dextromethorphan hydrobromide)
Number of subjects: 60
Study 6147193 — intervention group
Group type: COMPARATOR
Intervention: Expectorant containing diphenhydramine hydrochloride
Number of subjects: 60
Study 28392194 — intervention group
Group type: EXPERIMENTAL
Intervention: EB-NLFC hearing aids
Number of subjects: 14
Study 28392194 — intervention group
Group type: COMPARATOR
Intervention: NLFC hearing aids
Number of subjects: 14
Study 28271540 — intervention group
Group type: EXPERIMENTAL
Intervention: V0034CR emollient
Number of subjects: 335
Study 28271540 — intervention group
Group type: COMPARATOR
Intervention: No emollient
Number of subjects: 335
Study 26317458 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning (specifics not provided)
Number of subjects: 0
Study 26317458 — intervention group
Group type: EXPERIMENTAL
Intervention: Video assignments (specifics not provided)
Number of subjects: 0
Study 24169289 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-adhesion modified chitosan (Baifeimi) applied during surgery
Number of subjects: 42
Study 24169289 — intervention group
Group type: COMPARATOR
Intervention: Routine chest closing without application of Baifeimi (Control)
Number of subjects: 42
Study 21415838 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 18222194 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 410